Pediatric Blood & Cancer · 2009 · 60 citations · 14 references
MedicineOncologyPediatricsNeuro-oncologyPediatric NeurologyPediatric OncologyBrain TumorsCentral Nervous System TumorsPediatric Brain TumorsPediatric Neuro-oncologyPediatric TumorsTuberous Sclerosis ComplexMammalian Target Of Rapamycin SignalingPediatric Central Nervous System PathologyPediatric Central Nervous System TumorsSubependymal Giant Cell AstrocytomaSystematic Literature ReviewTuberous Sclerosis Complex Signaling
Tuberous sclerosis complex (TSC) is associated with hamartomatous growths including subependymal giant cell astrocytomas (SEGAs). Since chemo-radiation therapies offer scant benefit, oncologists had traditionally been little involved in managing SEGAs. Recent evidence demonstrating rapamycin efficacy in adults and children with TSC-associated tumors foresee a practice change. We summarize our institutional experience and literature review that highlight potential benefits and hazards of rapamycin therapy, for TSC patients with SEGA, and other syndromal brain tumors.
14
Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Dan Ehninger, Sangyeul Han, Carrie Shilyansky et al. · Nature Medicine · 2008 · 858 citations · Full text
Medicine, Neurobiology, Neuroscience +13
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
Ling-Hui Zeng, Lin Xu, David H. Gutmann et al. · Annals of Neurology · 2008 · 632 citations · Full text
Medicine, Neurology, Neuroscience +17
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
David Neal Franz, Jennifer Leonard, Cynthia Tudor et al. · Annals of Neurology · 2006 · 615 citations